milnacipran has been researched along with Sleep Wake Disorders in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aamir, R; Ahmed, M; Jishi, Z; Scharf, MB | 1 |
| Clauw, DJ; Geisser, ME; Gendreau, MR; Palmer, R; Strand, V; Williams, DA | 1 |
| Imai, S; Kuzumaki, N; Narita, M; Rahmadi, M; Suzuki, T; Yamashita, A | 1 |
| Dundon, K; Mease, PJ; Sarzi-Puttini, P | 1 |
| Rizzi, M; Sarzi-Puttini, P; Spaeth, M | 1 |
2 review(s) available for milnacipran and Sleep Wake Disorders
| Article | Year |
|---|---|
Pharmacotherapy of fibromyalgia.
Topics: Analgesics; Chronic Pain; Clinical Trials as Topic; Cognition Disorders; Cyclopropanes; Duloxetine Hydrochloride; Fatigue; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Milnacipran; Mood Disorders; Pain Management; Pregabalin; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders; Syndrome; Thiophenes; Treatment Outcome | 2011 |
Fibromyalgia and sleep.
Topics: Analgesics; Central Nervous System Sensitization; Chronic Pain; Cyclopropanes; Duloxetine Hydrochloride; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Milnacipran; Physical Therapy Modalities; Polysomnography; Pregabalin; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Wake Disorders; Syndrome; Thiophenes | 2011 |
2 trial(s) available for milnacipran and Sleep Wake Disorders
| Article | Year |
|---|---|
The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study.
Topics: Adult; Aged; Cross-Over Studies; Cyclopropanes; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fibromyalgia; Humans; Male; Middle Aged; Milnacipran; Patient Satisfaction; Polysomnography; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Sleep Wake Disorders; Treatment Outcome | 2016 |
Contributions of change in clinical status parameters to Patient Global Impression of Change (PGIC) scores among persons with fibromyalgia treated with milnacipran.
Topics: Activities of Daily Living; Adult; Cognition Disorders; Cyclopropanes; Depressive Disorder; Drug Resistance; Female; Fibromyalgia; Humans; Male; Middle Aged; Milnacipran; Outcome Assessment, Health Care; Pain Measurement; Patient Satisfaction; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders; Treatment Outcome | 2010 |
1 other study(ies) available for milnacipran and Sleep Wake Disorders
| Article | Year |
|---|---|
Sleep disturbance associated with an enhanced orexinergic system induced by chronic treatment with paroxetine and milnacipran.
Topics: Animals; Brain; Cyclopropanes; Electroencephalography; Electromyography; Histamine; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Milnacipran; Neuropeptides; Orexin Receptors; Orexins; Paroxetine; Receptors, Histamine; Receptors, Neuropeptide; Reverse Transcriptase Polymerase Chain Reaction; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Wake Disorders; Synaptic Transmission | 2011 |